Advisor Os, LLC Eli Lilly & CO Transaction History

Advisor Os, LLC

$968 Million
Q3 2024

A detailed history of Advisor Os, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisor Os, LLC holds 5,103 shares of LLY stock, worth $3.82 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

5,103

Previous 4,690 8.81%

Holding current value

$3.82 Million

Previous $4.25 Million 6.45%

% of portfolio

0.47%

Previous 0.48%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $318,893 - $396,488	413 Added 8.81%	5,103 $4.52 Million
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $115,254 - $144,537	159 Added 3.51%	4,690 $4.25 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $291,362 - $389,801	492 Added 12.18%	4,531 $3.52 Million
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $723,186 - $852,542	1,377 Added 51.73%	4,039 $2.35 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $105,197 - $145,030	242 Added 10.0%	2,662 $1.43 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $467,185 - $624,681	1,332 Added 122.43%	2,420 $1.13 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $21,433 - $25,172	69 Added 6.77%	1,088 $373,000
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $47,589 - $55,451	148 Added 16.99%	1,019 $372,000
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $12,155 - $13,852	41 Added 4.94%	871 $282,000
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $71,580 - $88,956	-305 Reduced 26.87%	830 $237,000
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $8,544 - $10,603	38 Added 3.46%	1,135 $314,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $3,102 - $3,817	-14 Reduced 1.26%	1,097 $253,000
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $2,527 - $3,269	14 Added 1.28%	1,111 $255,000
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $180,259 - $233,353	1,097 New	1,097 $205,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Os, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Os, LLC with notifications on news.

Account